Mounting competition and diminishing differentiation are pushing brand managers outside of their comfort zones. More than ever, launch strategies need to embrace new ideas, new techniques and new insights to hit the ground running.
IQVIA helps customer rise to the challenge, using the latest in machine learning to mine mountains of data and uncover game-changing insights about markets, channels and customers. The result is a more confident, more empowered, launch strategy.
Our team is ready to help with
To make the right decisions for your brand, today and down the road, understanding the disease is only part of the equation. In each therapeutic category you need to know what's different about the market, the regulations, the patient journey. You need to know the questions to ask, and what trends are making an impact.
With a legacy of support for over 5,000 product launches in over 120 therapeutic areas and 100 countries, IQVIA brings deep knowledge of underlying disease mechanisms, clinical manifestations, progress, biomarkers, and other factors needed to help you differentiate your drug more effectively right from the start.
Go beyond the numbers to analytics-driven insights using artificial intelligence, machine learning and healthcare expertise.
Access 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies and be ready for what’s next.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.